Live Status Check

NCT06121011 Recruiting Status

Real-time enrollment status for this pompe disease clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 7:38 AM UTC

NCT06121011 Status Summary

NCT NumberNCT06121011
Recruiting StatusRecruiting
ConditionPompe Disease
PhaseClinical Trial
Target Enrollment500 participants
Active Locations15 sites in the US
SponsorAmicus Therapeutics
Last Updated on CT.govMarch 10, 2026 (Mar 10, 2026)

About NCT06121011 Enrollment Status

As of July 13, 2026: Clinical trial NCT06121011 is currently recruiting participants. This clinical trial study for pompe disease is actively seeking new participants at 15 locations across the United States. The study is sponsored by Amicus Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06121011

Is NCT06121011 still recruiting?

Yes, NCT06121011 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06121011 recruiting?

This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06121011?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06121011 status last updated?

The official ClinicalTrials.gov record for NCT06121011 was last updated Mar 10, 2026 (March 10, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial